Aliquoting is the practice of dividing a larger sample into smaller, separate portions so that each portion can be used independently without disturbing the rest. It is one of the most routine procedures in any laboratory, and its importance comes down to a simple problem: every time you open, thaw, or handle a stored biological sample, you risk degrading it. By splitting a sample into multiple smaller volumes from the start, you can pull out just what you need for a single experiment or test while the remaining portions stay sealed and untouched in storage. The concept sounds almost too simple to matter, but poor aliquoting practices are a surprisingly common source of irreproducible results and wasted samples.
Why Repeated Freezing and Thawing Is the Core Problem
Most biological samples, whether blood plasma, purified DNA, cell suspensions, or protein solutions, are stored frozen. When a researcher needs to run an assay, they thaw the sample, take what they need, and refreeze the remainder. Each of those freeze-thaw cycles inflicts damage. Ice crystals form and disrupt cell membranes, proteins unfold and aggregate, and nucleic acids fragment. A single cycle might cause negligible harm, but the damage accumulates. By the fifth or tenth thaw, the sample may no longer reflect the biology it was collected to represent.
Aliquoting sidesteps this entirely. If you split a 10-milliliter blood plasma sample into twenty 0.5-milliliter tubes on the day of collection, each tube only ever gets thawed once, right before it is used. The other nineteen tubes remain in pristine condition. Biobanking guidelines consistently identify this as a primary strategy for preserving specimen quality over years or even decades of storage.1PubMed Central. Procurement, storage, and use of blood in biobanks
What Freeze-Thaw Actually Does to DNA and RNA
The damage is not abstract. Studies using pulsed field gel electrophoresis have tracked the progressive fragmentation of genomic DNA through repeated freeze-thaw cycles. DNA molecules larger than 100 kilobases are the most vulnerable, and by the eighteenth cycle, the average molecular size of all samples tested had dropped to around 25 kilobases regardless of where they started.2PubMed Central. Characterization of effect of repeated freeze and thaw cycles on stability of genomic DNA using pulsed field gel electrophoresis That kind of fragmentation can make certain downstream analyses impossible. If your experiment depends on having long, intact stretches of DNA, even a handful of unnecessary freeze-thaw cycles can render the sample useless.
RNA is even more fragile. Work examining poly(A)-enriched RNA sequencing found that as few as three freeze-thaw cycles were enough to destroy the reproducibility of differential expression results. The damage also introduced a shift in where sequencing reads mapped along genes, meaning the degradation was not random but systematically biased the data. Library preparation methods could even amplify the degradation artifacts rather than mask them.3PubMed Central. Multiple freeze-thaw cycles lead to a loss of consistency in poly(A)-enriched RNA sequencing This is the kind of problem that does not announce itself. A researcher might get results that look plausible but are actually shaped more by sample handling than by biology. Aliquoting at the point of collection is the most straightforward defense.
Biobanking at Scale
The importance of aliquoting becomes most visible in large biobanks, where hundreds of thousands of samples are stored for studies that might not happen for years. The UK Biobank, one of the largest population health resources in the world, collects blood and urine from participants and processes them into aliquots of plasma, serum, white cells, and red cells. By the end of its recruitment phase, the project had stored roughly 15 million individual aliquots across two geographically separate archives, some at −80°C in automated freezers and others in liquid nitrogen at −180°C.4International Journal of Epidemiology. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine The sheer number of aliquots reflects a deliberate strategy: each tiny portion is intended for a single future analysis, so that no sample ever needs to be thawed more than once.
Achieving this at scale requires rethinking how aliquoting itself is done. Conventional manual pipetting works fine for a dozen tubes, but not for millions. High-density automated systems have been validated for aliquoting blood into 384-well format plates at volumes as small as 70 microliters per well, producing reproducible results across thousands of runs.5PubMed. Large scale biobanking of blood – the importance of high density sample processing procedures The move toward smaller aliquot volumes is itself a form of conservation: the less material you lock away in each tube, the more independent experiments a single donation can support.
Why Mixing Before Aliquoting Matters More Than You Think
Splitting a sample into smaller tubes only works if each tube actually contains the same thing. That sounds obvious, but it is a real failure mode. A study examining aliquoting practices at a biobank found that vials aliquoted from the same parent tube showed alarming variation in the concentration of the protein CA125, a cancer biomarker. The mean coefficient of variation across subjects was 0.25 for the first set of aliquoted vials, and the concentration in the fifth aliquoted vial was on average 1.66 times higher than in the third. The explanation was straightforward: the parent vials had not been mixed thoroughly before aliquoting, so earlier tubes got a different concentration than later ones.6Mary Ann Liebert, Inc., publishers. Laboratory detective work identifies a mishandling problem in sample aliquoting
This matters because a biobank typically cannot go back and recollect a sample. If one aliquot reads high and another reads low for the same patient, any study using those samples will incorporate that variability as if it were biological. Imagine a longitudinal study tracking a biomarker over time: a reading that jumps from one visit to the next might reflect disease progression, or it might reflect the fact that someone forgot to vortex a tube three years ago. The fix is mundane but essential: gentle, thorough mixing of the parent sample immediately before each aliquot is drawn.
Tube Choice and Protein Loss
The container you aliquot into is not a neutral vessel. Proteins in solution can adsorb onto the walls of plastic microtubes, and the effect is especially pronounced at low concentrations and in small volumes where the surface-to-volume ratio is high. A study evaluating different commercially available microtubes found that protein recovery rates ranged from less than 10% to over 90% depending on the tube brand and material.7PubMed Central. Evaluation of the Binding Preference of Microtubes for Nanoproteomics Sample Preparation That is not a rounding error. Choosing the wrong tube could mean losing the majority of your target protein before you even begin an experiment.
The mechanisms behind this loss are also more nuanced than simple sticking. Research on protein aggregation near plastic surfaces has shown that the interaction between proteins and container walls depends on both the material and whether the sample is being agitated. Measured protein losses were comparable between low-binding plastics (around 7%) and PTFE (around 5%), a material expected to be a strong binder due to its hydrophobic surface. The losses did not follow predicted patterns based on surface chemistry alone and did not occur without agitation, suggesting that the solid-liquid and air-liquid interfaces during handling play a role beyond static adsorption.8Scientific Reports. A proteome scale study reveals how plastic surfaces and agitation promote protein aggregation The practical lesson is that “low-bind” labels on tubes are helpful but not a guarantee, and rough handling during aliquoting can introduce losses that careful pipetting avoids.
Pipetting Technique and Volume Effects
Aliquoting ultimately depends on pipetting, and the precision of pipetting varies with volume. A comparative study of pipetting performance across laboratory personnel found that variability increased at very small volumes, with 10-microliter transfers showing the highest inconsistency. The amplified error at tiny volumes comes from a combination of user technique, pipette tip quality, and environmental factors like evaporation from the tip before the liquid reaches the receiving tube.9The Journal of Applied Laboratory Medicine. Pipetting Performance across Laboratory Personnel: A Comparative Study
For most routine aliquoting, volumes of 50 microliters or above are forgiving enough that a trained technician can achieve consistent results with a standard air-displacement pipette. Below that threshold, small errors in technique get magnified. If your experimental design requires very small aliquots, investing in calibrated positive-displacement pipettes, using fresh tips for each transfer, and working quickly to minimize evaporation all become more consequential. In high-throughput settings, robotic liquid handlers take over because they eliminate the human variability entirely.
Automation and High-Throughput Pipelines
When a laboratory needs to process hundreds of samples per day, manual aliquoting becomes both a bottleneck and a source of error. Automated liquid-handling platforms can aliquot, label, and track samples with a consistency that manual methods cannot match. One protein-production pipeline used semi-automated aliquoting to format purified proteins into 96-well plates for cell-based assays, sustaining an average throughput of 280 proteins per month over a four-year period.10PubMed Central. A high-throughput mammalian protein expression, purification, aliquoting and storage pipeline to assemble a library of the human secretome That kind of sustained output would be impractical with manual pipetting, not because any single aliquoting step is difficult, but because the cumulative risk of mislabeling, cross-contamination, or volume drift compounds across thousands of repetitions.
Automation also helps with traceability. Robotic systems log which sample went into which tube, at what time, and in what volume, creating an auditable chain of custody that regulatory bodies and quality-management systems increasingly demand. For clinical biobanks in particular, where a sample might sit in a freezer for ten years before being tested, the ability to confirm exactly how it was handled on the day of collection is valuable insurance against future questions about data quality.
Cell Cryopreservation and the Role of Aliquoting
Aliquoting is not limited to cell-free fluids like serum or purified DNA. When researchers or clinical labs need to store living cells, they freeze them in cryovials with a cryoprotective agent, most commonly DMSO at around 10%, using a controlled cooling rate of roughly 1°C per minute and storage in liquid or vapor-phase nitrogen.11PubMed Central. Cryopreservation: An Overview of Principles and Cell-Specific Considerations Each cryovial is essentially an aliquot of the original cell population, and the same freeze-thaw logic applies: you thaw one vial when you need cells, and the rest stay frozen.
Cell banks, whether for research cell lines or for therapeutic products like CAR-T cells, are typically structured as a tiered aliquoting system. A master cell bank is a set of aliquots made from a single large batch of cells at a defined passage number. Working cell banks are then created by thawing one master-bank vial and expanding those cells before re-aliquoting and refreezing. This layered approach means you can go back to a genetically identical starting population years later without ever having to thaw your original master stock more than once per working bank creation. The discipline of keeping each vial as a one-use item is what makes long-term cell banking viable.
Aliquoting in Low-Resource and Field Settings
Laboratory aliquoting typically involves pipettes, freezers, and controlled environments, but the principle extends to field diagnostics and resource-limited settings where none of that infrastructure exists. Microfluidic diagnostic cards have been designed to perform sample preparation steps, including plasma filtration from whole blood and aliquoting of sample and reagents into parallel assay channels, all within a self-contained disposable device.12PubMed. Progress toward multiplexed sample-to-result detection in low resource settings using microfluidic immunoassay cards The aliquoting here is built into the card’s geometry rather than performed by a technician with a pipette, but the purpose is the same: splitting a single sample into the right volumes for each test without requiring additional equipment.
This kind of design matters in contexts like remote clinics or outbreak investigations, where samples need to be tested on-site and there is no opportunity to bring them back to a central lab for processing. The ability to aliquot a blood sample into multiple parallel assays within a single device means that a small finger-prick volume can yield results for more than one target, stretching limited sample material further. It is the same resource-conservation logic that drives biobank aliquoting, just miniaturized and made disposable.
Evaporation as a Silent Aliquoting Hazard
When working with very small volumes, evaporation becomes a serious concern. A 5-microliter droplet sitting in an open well on a lab bench can lose a meaningful fraction of its volume in minutes, concentrating whatever is dissolved in it and throwing off assay results. This is particularly relevant in high-throughput screening, where microwell plates hold hundreds or thousands of tiny aliquots exposed to air. Research into volume loss during microscale assays has formalized the problem, characterizing how factors like temperature, humidity, well geometry, and exposure time determine how quickly a small aliquot dries out.13Europe PMC. Managing evaporation for more robust microscale assays. Part 1. Volume loss in high throughput assays.
The practical countermeasures are unglamorous but effective: seal plates with adhesive films or lids as soon as possible after dispensing, keep incubation times short, work in humidified environments when feasible, and avoid leaving small-volume aliquots uncovered while waiting for the next step. Some labs also add a thin layer of mineral oil over aqueous aliquots in open wells to create a physical barrier against evaporation, though this introduces its own compatibility concerns depending on the downstream assay. The point is that aliquoting is not finished when the liquid hits the receiving vessel. Preserving what you just dispensed requires attention to the minutes and hours that follow.
When Aliquoting Can Go Wrong
Beyond the mixing and evaporation pitfalls already described, several other failure modes trip up even experienced labs. Mislabeling is probably the most common and most damaging: swap two tube labels during a long aliquoting session and the resulting data may be silently wrong rather than obviously broken. Barcode-based labeling systems and double-check protocols exist specifically to combat this, but in practice, labeling errors persist because they are boring mistakes made during tedious work.
Cross-contamination is another risk, especially when using multichannel pipettes or repeating-dispenser tips that carry over trace amounts from one sample to the next. For nucleic acid work, where even femtograms of contaminating DNA can be amplified by PCR into a false signal, changing tips between every transfer is non-negotiable. For protein work, the stakes are usually lower but still real if the goal is quantitative measurement of a low-abundance analyte.
Finally, there is the question of how many aliquots to make. Too few and you run out, forcing a return to the parent sample and an extra freeze-thaw cycle that defeats the purpose. Too many and you waste material and freezer space, which are not unlimited resources, especially for rare or irreplaceable specimens. Getting this right requires thinking ahead about how many experiments the sample will support, what volume each experiment needs, and how much dead volume will be lost to the tube walls and pipette tip. It is a planning problem as much as a technical one, and the best time to solve it is before collection, not after.